Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth

Abstract Angiogenesis is a physiological process for the formation of new blood vessels from the pre-existing vessels and it has a vital role in the survival and growth of neoplasms. During tumor angiogenesis, the activation of the gene transcriptions in vascular endothelial cells (ECs) plays an ess...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huan Liu, Yikai Qiu, Xiuying Pei, Ramamurthy Chitteti, Rebbeca Steiner, Shuya Zhang, Zheng Gen Jin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9c4a57dd2aa34930a02d3214c650fdc3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9c4a57dd2aa34930a02d3214c650fdc3
record_format dspace
spelling oai:doaj.org-article:9c4a57dd2aa34930a02d3214c650fdc32021-12-02T15:10:19ZEndothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth10.1038/s41598-020-77568-z2045-2322https://doaj.org/article/9c4a57dd2aa34930a02d3214c650fdc32020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77568-zhttps://doaj.org/toc/2045-2322Abstract Angiogenesis is a physiological process for the formation of new blood vessels from the pre-existing vessels and it has a vital role in the survival and growth of neoplasms. During tumor angiogenesis, the activation of the gene transcriptions in vascular endothelial cells (ECs) plays an essential role in the promotion of EC proliferation, migration, and vascular network development. However, the molecular mechanisms underlying transcriptional regulation of EC and tumor angiogenesis remains to be fully elucidated. Here we report that the transcription factor Yin Yang 1 (YY1) in ECs is critically involved in tumor angiogenesis. First, we utilized a tamoxifen-inducible EC-specific YY1 deficient mouse model and showed that YY1 deletion in ECs inhibited the tumor growth and tumor angiogenesis. Using the in vivo matrigel plug assay, we then found that EC-specific YY1 ablation inhibited growth factor-induced angiogenesis. Furthermore, vascular endothelial growth factor (VEGF)-induced EC migration was diminished in YY1-depleted human umbilical vein endothelial cells (HUVECs). Finally, a rescue experiment revealed that YY1-regulated BMP6 expression in ECs was involved in EC migration. Collectively, our results demonstrate that endothelial YY1 has a crucial role in tumor angiogenesis and suggest that targeting endothelial YY1 could be a potential therapeutic strategy for cancer treatment.Huan LiuYikai QiuXiuying PeiRamamurthy ChittetiRebbeca SteinerShuya ZhangZheng Gen JinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Huan Liu
Yikai Qiu
Xiuying Pei
Ramamurthy Chitteti
Rebbeca Steiner
Shuya Zhang
Zheng Gen Jin
Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
description Abstract Angiogenesis is a physiological process for the formation of new blood vessels from the pre-existing vessels and it has a vital role in the survival and growth of neoplasms. During tumor angiogenesis, the activation of the gene transcriptions in vascular endothelial cells (ECs) plays an essential role in the promotion of EC proliferation, migration, and vascular network development. However, the molecular mechanisms underlying transcriptional regulation of EC and tumor angiogenesis remains to be fully elucidated. Here we report that the transcription factor Yin Yang 1 (YY1) in ECs is critically involved in tumor angiogenesis. First, we utilized a tamoxifen-inducible EC-specific YY1 deficient mouse model and showed that YY1 deletion in ECs inhibited the tumor growth and tumor angiogenesis. Using the in vivo matrigel plug assay, we then found that EC-specific YY1 ablation inhibited growth factor-induced angiogenesis. Furthermore, vascular endothelial growth factor (VEGF)-induced EC migration was diminished in YY1-depleted human umbilical vein endothelial cells (HUVECs). Finally, a rescue experiment revealed that YY1-regulated BMP6 expression in ECs was involved in EC migration. Collectively, our results demonstrate that endothelial YY1 has a crucial role in tumor angiogenesis and suggest that targeting endothelial YY1 could be a potential therapeutic strategy for cancer treatment.
format article
author Huan Liu
Yikai Qiu
Xiuying Pei
Ramamurthy Chitteti
Rebbeca Steiner
Shuya Zhang
Zheng Gen Jin
author_facet Huan Liu
Yikai Qiu
Xiuying Pei
Ramamurthy Chitteti
Rebbeca Steiner
Shuya Zhang
Zheng Gen Jin
author_sort Huan Liu
title Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
title_short Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
title_full Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
title_fullStr Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
title_full_unstemmed Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
title_sort endothelial specific yy1 deletion restricts tumor angiogenesis and tumor growth
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/9c4a57dd2aa34930a02d3214c650fdc3
work_keys_str_mv AT huanliu endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
AT yikaiqiu endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
AT xiuyingpei endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
AT ramamurthychitteti endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
AT rebbecasteiner endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
AT shuyazhang endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
AT zhenggenjin endothelialspecificyy1deletionrestrictstumorangiogenesisandtumorgrowth
_version_ 1718387707748548608